Paperpal Prime Logo

Expert Review of Pharmacoeconomics and Outcomes Research : Impact Factor & More

eISSN: 1744-8379pISSN: 1473-7167

Aims and Scope of Expert Review of Pharmacoeconomics and Outcomes Research

Expert Review of Pharmacoeconomics & Outcomes Research is a bimonthly peer-reviewed medical journal covering all aspects of pharmacoeconomics. It was established in 2001 and is published by Informa. The editor-in-chief is A. Bottomley (European Organisation for Research and Treatment of Cancer). Less

Key Metrics

CiteScore
3.4
H-Index
60
Impact Factor
< 5
SJR
Q2Health Policy
SNIP
0.9
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Expert Review of Pharmacoeconomics and Outcomes Research

Expert Review of Pharmacoeconomics and Outcomes Research Journal Specifications

Overview
Publisher TAYLOR & FRANCIS LTD
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2001
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Expert Review of Pharmacoeconomics and Outcomes Research ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Expert Review of Pharmacoeconomics and Outcomes Research

Principles of selecting cost-effectiveness thresholds in price-taker countries
  • 9 Aug 2026
  • Expert Review of Pharmacoeconomics & Outcomes Research
Economic evaluations of assisted reproductive technologies (ART) for specialized infertility treatment: a systematic review of IVF, IUI and ICSI
  • 9 Aug 2026
  • Expert Review of Pharmacoeconomics & Outcomes Research
Universal school-based mental health promotion in Vietnam: a critical appraisal of a health-economic evaluation
  • 9 Aug 2026
  • Expert Review of Pharmacoeconomics & Outcomes Research
Comparative landscape of artificial intelligence-assisted systematic literature reviews
  • 9 Aug 2026
  • Expert Review of Pharmacoeconomics & Outcomes Research
Single versus multiple inhaler triple therapy in COPD using data from the pragmatic INTREPID trial: cost-effectiveness analysis from the Chilean public healthcare system perspective
  • 9 Aug 2026
  • Expert Review of Pharmacoeconomics & Outcomes Research
Regulatory approval trends and market access implications: a multiregional comparative framework for New and supplemental Drug applications (2020-2025)
  • 9 Aug 2026
  • Expert Review of Pharmacoeconomics & Outcomes Research
Principles of selecting cost-effectiveness thresholds in price-taker countries
  • 9 Aug 2026
  • Expert Review of Pharmacoeconomics & Outcomes Research
Economic evaluations of assisted reproductive technologies (ART) for specialized infertility treatment: a systematic review of IVF, IUI and ICSI
  • 9 Aug 2026
  • Expert Review of Pharmacoeconomics & Outcomes Research
Universal school-based mental health promotion in Vietnam: a critical appraisal of a health-economic evaluation
  • 9 Aug 2026
  • Expert Review of Pharmacoeconomics & Outcomes Research
Comparative landscape of artificial intelligence-assisted systematic literature reviews
  • 9 Aug 2026
  • Expert Review of Pharmacoeconomics & Outcomes Research
Single versus multiple inhaler triple therapy in COPD using data from the pragmatic INTREPID trial: cost-effectiveness analysis from the Chilean public healthcare system perspective
  • 9 Aug 2026
  • Expert Review of Pharmacoeconomics & Outcomes Research
Regulatory approval trends and market access implications: a multiregional comparative framework for New and supplemental Drug applications (2020-2025)
  • 9 Aug 2026
  • Expert Review of Pharmacoeconomics & Outcomes Research

FAQs on Expert Review of Pharmacoeconomics and Outcomes Research